The increased stiffness, which occurs only in Mesenchymal HGSOC upon tumor growth, might contribute to the aggressiveness of this specific HGSOC molecular subtype by inducing MAPK/MEK signaling pathway, stromal metabolic switch and matrix remodeling. Here, MAP2K7 is linked to neoplasm.